CHR-M2; HM2; M-AChRM2; Muscarinic Acetylcholine Receptor M2; Cholinergic Receptor,Muscarinic 2
CHR-M2; HM2; M-AChRM2; Muscarinic Acetylcholine Receptor M2; Cholinergic Receptor,Muscarinic 2
BHLHB1; OLIGO2; PRKCBP2; RACK17; Basic Domain,Helix-Loop-Helix Protein,Class B 1; Class B basic helix-loop-helix protein 1; Class E basic helix-loop-helix protein 19
BHLHB1; OLIGO2; PRKCBP2; RACK17; Basic Domain,Helix-Loop-Helix Protein,Class B 1; Class B basic helix-loop-helix protein 1; Class E basic helix-loop-helix protein 19
THPO; MGDF; MKCSF; ML; MPLLG; Myeloproliferative Leukemia Virus Oncogene Ligand; Megakaryocyte Growth And Development Factor; Megakaryocyte Stimulating Factor
THPO; MGDF; MKCSF; ML; MPLLG; Myeloproliferative Leukemia Virus Oncogene Ligand; Megakaryocyte Growth And Development Factor; Megakaryocyte Stimulating Factor
AIE2; AIK3; AurC; STK13; ARK-3; Aurora-C; Serine/Threonine-Protein Kinase 13; Aurora/IPL1-related kinase 3; Aurora/IPL1/Eg2 protein 2; Serine/threonine-protein kinase aurora-C
AIE2; AIK3; AurC; STK13; ARK-3; Aurora-C; Serine/Threonine-Protein Kinase 13; Aurora/IPL1-related kinase 3; Aurora/IPL1/Eg2 protein 2; Serine/threonine-protein kinase aurora-C